FR2602682B1 - Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff - Google Patents

Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff

Info

Publication number
FR2602682B1
FR2602682B1 FR8611643A FR8611643A FR2602682B1 FR 2602682 B1 FR2602682 B1 FR 2602682B1 FR 8611643 A FR8611643 A FR 8611643A FR 8611643 A FR8611643 A FR 8611643A FR 2602682 B1 FR2602682 B1 FR 2602682B1
Authority
FR
France
Prior art keywords
osid
immunotoxins
vivo
oxidation
patterns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8611643A
Other languages
English (en)
Other versions
FR2602682A1 (fr
Inventor
Pierre Casellas
Bernard Bourrie
Xavier Canat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR8611643A priority Critical patent/FR2602682B1/fr
Priority to IL80972A priority patent/IL80972A/xx
Priority to US06/941,990 priority patent/US4911911A/en
Priority to AT86402812T priority patent/ATE59049T1/de
Priority to EP86402812A priority patent/EP0234151B1/fr
Priority to DE8686402812T priority patent/DE3676187D1/de
Priority to ES86402812T priority patent/ES2020945B3/es
Priority to PT83946A priority patent/PT83946B/pt
Priority to AU66630/86A priority patent/AU602320B2/en
Priority to CA000525646A priority patent/CA1276108C/fr
Priority to IE330586A priority patent/IE59649B1/en
Priority to DK611886A priority patent/DK611886A/da
Priority to NZ218705A priority patent/NZ218705A/xx
Priority to AR86306243A priority patent/AR242958A1/es
Priority to JP61302889A priority patent/JPH0742316B2/ja
Priority to KR1019860011019A priority patent/KR950007215B1/ko
Publication of FR2602682A1 publication Critical patent/FR2602682A1/fr
Application granted granted Critical
Publication of FR2602682B1 publication Critical patent/FR2602682B1/fr
Priority to US07/404,052 priority patent/US5104976A/en
Priority to GR91400316T priority patent/GR3001597T3/el
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6817—Toxins
    • A61K47/6819—Plant toxins
    • A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6889—Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Botany (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR8611643A 1985-12-20 1986-08-12 Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff Expired FR2602682B1 (fr)

Priority Applications (18)

Application Number Priority Date Filing Date Title
FR8611643A FR2602682B1 (fr) 1986-08-12 1986-08-12 Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff
IL80972A IL80972A (en) 1985-12-20 1986-12-15 Modified ribosome-inactivating glycoproteins,their preparation,immunotoxins containing them and pharmaceutical compositions containing such immunotoxins
US06/941,990 US4911911A (en) 1985-12-20 1986-12-15 Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein
EP86402812A EP0234151B1 (fr) 1985-12-20 1986-12-16 Glycoprotéines modifiées par oxydation et formation de base de Schiff, inhibant les ribosomes, procédé d'obtention et immunotoxines comprenant une telle glycoprotéine
DE8686402812T DE3676187D1 (de) 1985-12-20 1986-12-16 Die ribosome inhibierende, mittels oxidation und bildung von schiffbasen modifizierte glukoproteine, verfahren zur herstellung derselben und ein solches glukoprotein enthaltende immunotoxine.
ES86402812T ES2020945B3 (es) 1985-12-20 1986-12-16 Glicoproteinas modificadas por oxidacion y formacion de bases de schiff, que inhiben los ribosomas, procedimiento de obtencion e inmunotoxinas que comprenden una glicoproteina como esta.
AT86402812T ATE59049T1 (de) 1985-12-20 1986-12-16 Die ribosome inhibierende, mittels oxidation und bildung von schiffbasen modifizierte glukoproteine, verfahren zur herstellung derselben und ein solches glukoprotein enthaltende immunotoxine.
AU66630/86A AU602320B2 (en) 1985-12-20 1986-12-17 Ribosome inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged-action immunotoxins containing such a glycoprotein
PT83946A PT83946B (pt) 1985-12-20 1986-12-17 Processo para a obtencao de glicoproteinas inibidoras dos ribosomas, modificadas por oxidacao das funcoes osidicas e formacao de uma base de schiff
CA000525646A CA1276108C (fr) 1985-12-20 1986-12-17 Procede de modification des glycoproteines inactivant les ribosomes par oxydation des groupements oside et formation d'une base de schiff
DK611886A DK611886A (da) 1985-12-20 1986-12-18 Riboson-inaktiverende glycoproteiner og immunotoksiner med forlaengetvirkning in vivo, der indeholder et saadant glycoprotein
NZ218705A NZ218705A (en) 1985-12-20 1986-12-18 Glycoproteins with ribosome-inhibiting properties and immunotoxins
IE330586A IE59649B1 (en) 1985-12-20 1986-12-18 Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and invivo prolonged-action immunotoxins containing such a glycoprotein
AR86306243A AR242958A1 (es) 1985-12-20 1986-12-19 Un procedimiento para la obtencion de un gpir modificada, y procedimiento para obtener una inmunotoxina utilizando dicho gpir modificada.
JP61302889A JPH0742316B2 (ja) 1985-12-20 1986-12-20 オシド単位の酸化およびシツフ塩基の形成により変性されたリボソ−ム不活性化糖タンパク、およびこの糖タンパクを含む生体内持続性免疫毒素
KR1019860011019A KR950007215B1 (ko) 1985-12-20 1986-12-20 오시딕 단위를 산화시키고 쉬프염기를 형성하여 리보솜을 비활성화시키는 당단백질을 변형시키는 방법
US07/404,052 US5104976A (en) 1985-12-20 1989-09-08 Ribosome-inactivating glycoproteins, modified by oxidation of their osidic units and formation of a schiff's base and in-vivo prolonged action immunotoxins containing such a glycoprotein
GR91400316T GR3001597T3 (en) 1985-12-20 1991-03-12 Glycoproteins modified by oxidation and formation of schiff bases, inhibiting ribosomes, process for obtaining the same, and immunotoxines containing such glycoprotein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8611643A FR2602682B1 (fr) 1986-08-12 1986-08-12 Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff

Publications (2)

Publication Number Publication Date
FR2602682A1 FR2602682A1 (fr) 1988-02-19
FR2602682B1 true FR2602682B1 (fr) 1988-12-02

Family

ID=9338239

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8611643A Expired FR2602682B1 (fr) 1985-12-20 1986-08-12 Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff

Country Status (1)

Country Link
FR (1) FR2602682B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664911A (en) * 1983-06-21 1987-05-12 Board Of Regents, University Of Texas System Immunotoxin conjugates employing toxin B chain moieties
PT80662B (en) * 1984-06-20 1986-12-09 Sanofi Sa Process to obtain anti-tumoral glycoprotein modified on its glycidic portions

Also Published As

Publication number Publication date
FR2602682A1 (fr) 1988-02-19

Similar Documents

Publication Publication Date Title
IL134374A0 (en) Preparation of 3,3-dimethylbutyraldehyde by oxidation of 3,3-dimethylbutanol
FR2703993B1 (fr) Utilisation en cosmétique de dérivés lipophiles des amino déoxyalditols, compositions cosmétiques les contenant, et nouveaux carbamates d'alkyle.
IT1284758B1 (it) Utilizzo della vitamina c o di suoi derivati o analoghi per stimolare la sintesi dell'elastina cutanea.
PL335160A1 (en) Treatment of hiv and carcinoma
IL92337A (en) Combined shirt and religious garment
EP0239391A3 (en) New 1,2,6-triphenyl-4(1h)- pyridinone and pyridinethione derivatives, production and uses thereof
DE3752293D1 (de) Neue Blockcopolymere und ihre Herstellung
DE3674375D1 (de) Fluessigkeitsgekuehlter homopolargeneratorlaeufer und sein herstellungsverfahren.
GB2156806B (en) Production of diphenylamines or n,n'-diphenyl-phenylenediamines
GB2216891B (en) 'plant ribosome inactivating protein derived from saponaria officinalis'
FR2602682B1 (fr) Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques et formation d'une base de schiff
FR2602683B1 (fr) Immunotoxines a longue duree d'action in vivo comportant une glycoproteine inhibant les ribosomes, modifiee par oxydation des motifs osidiques puis reduction
PT83946A (fr) Procede pour l:obtention de glycoproteines inhibant les ribosomes modifiees par oxydation des motifs osidiques et formation d:une base de schiff
ZA894541B (en) Selective production of 2,6-diethylnaphthalene
NO975869D0 (no) Forbedret syntese av 2,4,6,8,10,12-heksabenzyl-2,4,6,8,10,12-heksaazatetracyklo£5,5,0,05,9,03,11|dodecan
FR2591895B1 (fr) Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques
CZ78095A3 (en) Novel 17 beta-substituted derivatives of 4-azaandrostane, pharmaceutical preparations based thereon and process of their preparation
MA22329A1 (fr) Pain de detergent synthetique avec des sulfates d'alkyle a longue chaine pour ameliorer la faculte de mise en oeuvre et les caracteristiques du pain
DE69006508D1 (de) Azeotropähnliche zusammensetzungen von 1,3-dichlor-1,1,2,2,3-pentafluorpropan und 2-methyl-2-propanol.
DE3777779D1 (de) Behandlung des haares.
FR2591894B1 (fr) Immunotoxines a longue duree d'action in vivo comportant la chaine a de ricine modifiee sur ses motifs polysaccharidiques
FR2583789B1 (fr) Transporteur a chaines a pinces d'une machine a tendre les bandes de tissu.
FR2653996B1 (fr) Composition et solution aqueuse pour la repousse des cheveux.
FR2755968B1 (fr) Nouveaux derives silicies de flavones filtres, compositions cosmetiques photoprotectrices les contenant et utilisations
OA09221A (fr) "Synthèse asymétrique des dérivés de la furo (3, 4-c) pyridine".

Legal Events

Date Code Title Description
ST Notification of lapse